CytRx Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.42 |
Market Cap |
$12.36 M |
Shares Outstanding |
33.64 M |
Public Float |
30.78 M |
Address |
11726 San Vicente Boulevard Los Angeles California 90049 United States |
Employees | - |
Website | http://www.cytrx.com |
Updated | 07/08/2019 |
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It focuses on discovering, developing, and commercializing new therapeutics to treat patients with cancer; including aldoxorubicin, a modified version of the widely-used chemotherapeutic agent, doxorubicin. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA. |